580 Appendices 458. Merten MM, Castro MR, Zhang J, Durski J, Ryder M. Examining the Role of Preoperative Positron Emission Tomography/Computerized Tomography in Combination with Ultrasonography in Discriminating Benign from Malignant Cytologically Indeterminate Thyroid Nodules. Thyroid. 2016;27:95-102. https://doi.org/10.1089/ thy.2016.0379. 459. Giovanella L, Milan L, Piccardo A, Bottoni G, Cuzzocrea M, Paone G, et al. Radiomics analysis improves (18)FDG PET/ CT-based risk stratification of cytologically indeterminate thyroid nodules. Endocrine. 2022;75:202-210. https://doi. org/10.1007/s12020-021-02856-1. 460. de Koster EJ, Vriens D, van Aken MO, Dijkhorst-Oei LT, Oyen WJG, Peeters RP, et al. FDG-PET/CT in indeterminate thyroid nodules: cost-utility analysis alongside a randomised controlled trial. Eur J Nucl Med Mol Imaging. 2022. https://doi.org/10.1007/s00259-022-05794-w. 461. de Koster EJ, Husson O, van Dam EWCM, Mijnhout GS, Netea-Maier RT, Oyen WJG, et al. Health-related quality of life following FDG-PET/CT for cytological indeterminate thyroid nodules %J Endocrine Connections. 2022;11:e220014. https://doi.org/10.1530/ec-22-0014. 462. Trimboli P, Piccardo A, Alevizaki M, Virili C, Naseri M, Sola S, et al. Dedicated neck (18) F-FDG PET/CT: An additional tool for risk assessment in thyroid nodules at ultrasound intermediate risk. Clinical endocrinology. 2019;90:737-743. https://doi.org/10.1111/cen.13949. 463. National Cancer Institute. Surveillance, Epidemiology, and End Results (SEER) Program. CancerStat Facts: Thyroid Cancer. 2020. https://seer.cancer.gov/statfacts/html/thyro.html. Accessed 7 July 2021. 464. Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The Diagnosis and Management of Thyroid Nodules: A Review. JAMA. 2018;319:914–924. https://doi.org/10.1001/jama.2018.0898. 465. Vriens D, de Wilt JH, van der Wilt GJ, Netea-Maier RT, Oyen WJ, de Geus-Oei LF. The role of [18F]-2-fluoro-2-deoxyd-glucose-positron emission tomography in thyroid nodules with indeterminate fine-needle aspiration biopsy: systematic review and meta-analysis of the literature. Cancer. 2011;117:4582–4594. https://doi.org/10.1002/ cncr.26085. 466. Rosato L, Avenia N, Bernante P, De Palma M, Gulino G, Nasi PG, et al. Complications of thyroid surgery: analysis of a multicentric study on 14,934 patients operated on in Italy over 5 years. World journal of surgery. 2004;28:271–276. https://doi.org/10.1007/s00268-003-6903-1. 467. Evidence Based Nation-wide Guideline Thyroid Carcinoma version 2.0. 2015. https://richtlijnendatabase.nl/richtlijn/ schildkliercarcinoom/. Accessed 7 Jul 2023. 468. Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, et al. FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42:328-354. https://doi.org/10.1007/ s00259-014-2961-x. 469. Giovanella L, Avram AM, Iakovou I, Kwak J, Lawson SA, Lulaj E, et al. EANM practice guideline/SNMMI procedure standard for RAIU and thyroid scintigraphy. Eur J Nucl Med Mol Imaging. 2019;46:2514-2525. https://doi.org/10.1007/ s00259-019-04472-8. 470. EQ-5D-5L User Guide. 2019. https://euroqol.org/publications/user-guides. Accessed 7 Jul 2021. 471. Herdman M, Gudex C, Lloyd A, Janssen M, Kind P, Parkin D, et al. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of life research. 2011;20:1727-1736. https://doi.org/10.1007/s11136011-9903-x. 472. Bouwmans C, Krol M, Severens H, Koopmanschap M, Brouwer W, Hakkaart-van Roijen L. The iMTA Productivity Cost Questionnaire: A Standardized Instrument for Measuring and Valuing Health-Related Productivity Losses. Value in health. 2015;18:753-758. https://doi.org/10.1016/j.jval.2015.05.009. 473. iMTA Productivity and Health Research Group. Manual iMTA Medical Cost Questionnaire (iMCQ). https://www.imta. nl/. Accessed 7 Jul 2021. 474. Versteegh MM, Vermeulen KM, Evers SMAA, de Wit GA, Prenger R, Stolk EA. Dutch Tariff for the Five-Level Version of EQ-5D. Value in health. 2016;19:343–352. https://doi.org/10.1016/j.jval.2016.01.003. 475. Stiggelbout AM, Eijkemans MJ, Kiebert GM, Kievit J, Leer JW, De Haes HJ. The ‘utility’ of the visual analog scale in medical decision making and technology assessment. Is it an alternative to the time trade-off? International journal of technology assessment in health care. 1996;12:291-298. https://doi.org/10.1017/s0266462300009648. 476. Dutch Healthcare Authority (NZa). Open data of the Dutch Healthcare Authority (NZa). 2020. https://opendisdata. nl/. Accessed 24 Aug 2021. 477. Hakkaart-van Roijen L, Van der Linden N, Bouwmans CAM, Kanters TA, Tan SS. Costing manual: Methodology of costing research and reference prices for economic evaluations in healthcare [in Dutch: Kostenhandleiding: Methodologie van kostenonderzoek en referentieprijzen voor economische evaluaties in de gezondheidszorg]. Rotterdam, the Netherlands; 2015. 478. Dutch Consumer Price index. https://opendata.cbs.nl/statline/#/CBS/nl/. Accessed 14 Apr 2021.
RkJQdWJsaXNoZXIy MTk4NDMw